Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial
OBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income countries is scarce. We aimed to describe differences between younger and older adults with HIV starting antiretroviral therapy in two low-income African countries. METHODS: SETTING: HIV clinics in Ugand...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Public Library of Science
2013
|
| _version_ | 1797088472928878592 |
|---|---|
| author | Parikh, S Obuku, E Walker, SA Semeere, A Auerbach, B Hakim, J Mayanja-Kizza, H Mugyenyi, P Salata, R Kityo, C |
| author_facet | Parikh, S Obuku, E Walker, SA Semeere, A Auerbach, B Hakim, J Mayanja-Kizza, H Mugyenyi, P Salata, R Kityo, C |
| author_sort | Parikh, S |
| collection | OXFORD |
| description | OBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income countries is scarce. We aimed to describe differences between younger and older adults with HIV starting antiretroviral therapy in two low-income African countries. METHODS: SETTING: HIV clinics in Uganda and Zimbabwe. DESIGN: Secondary exploratory cross-sectional analysis of the DART randomized controlled trial. OUTCOME MEASURES: Clinical and laboratory characteristics were compared between adults aged 18-49 years (younger) and ≥ 50 years (older), using two exploratory multivariable logistic regression models, one with HIV viral load (measured in a subset pre-ART) and one without. RESULTS: A total of 3316 eligible participants enrolled in DART were available for analysis; 219 (7%) were ≥ 50 years and 1160 (35%) were male. Across the two adjusted regression models, older adults had significantly higher systolic blood pressure, lower creatinine clearance and were consistently less likely to be females compared to younger adults with HIV. Paradoxically, the models separately suggested that older adults had statistically significant (but not clinically important) higher CD4+ cell counts and higher plasma HIV-1 viral copies at initiation. Crude associations between older age and higher baseline hemoglobin, body mass index, diastolic blood pressure and lower WHO clinical stage were not sustained in the adjusted analysis. CONCLUSIONS: Our study found clinical and immunological differences between younger and older adults, in a cohort of Africans starting antiretroviral therapy. Further investigations should explore how these differences could be used to ensure equity in service delivery and affect outcomes of antiretroviral therapy. |
| first_indexed | 2024-03-07T02:50:36Z |
| format | Journal article |
| id | oxford-uuid:ad8dec13-4baf-49c3-9efd-6c1275d6d02f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:50:36Z |
| publishDate | 2013 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:ad8dec13-4baf-49c3-9efd-6c1275d6d02f2022-03-27T03:36:24ZClinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trialJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ad8dec13-4baf-49c3-9efd-6c1275d6d02fEnglishSymplectic Elements at OxfordPublic Library of Science2013Parikh, SObuku, EWalker, SASemeere, AAuerbach, BHakim, JMayanja-Kizza, HMugyenyi, PSalata, RKityo, COBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income countries is scarce. We aimed to describe differences between younger and older adults with HIV starting antiretroviral therapy in two low-income African countries. METHODS: SETTING: HIV clinics in Uganda and Zimbabwe. DESIGN: Secondary exploratory cross-sectional analysis of the DART randomized controlled trial. OUTCOME MEASURES: Clinical and laboratory characteristics were compared between adults aged 18-49 years (younger) and ≥ 50 years (older), using two exploratory multivariable logistic regression models, one with HIV viral load (measured in a subset pre-ART) and one without. RESULTS: A total of 3316 eligible participants enrolled in DART were available for analysis; 219 (7%) were ≥ 50 years and 1160 (35%) were male. Across the two adjusted regression models, older adults had significantly higher systolic blood pressure, lower creatinine clearance and were consistently less likely to be females compared to younger adults with HIV. Paradoxically, the models separately suggested that older adults had statistically significant (but not clinically important) higher CD4+ cell counts and higher plasma HIV-1 viral copies at initiation. Crude associations between older age and higher baseline hemoglobin, body mass index, diastolic blood pressure and lower WHO clinical stage were not sustained in the adjusted analysis. CONCLUSIONS: Our study found clinical and immunological differences between younger and older adults, in a cohort of Africans starting antiretroviral therapy. Further investigations should explore how these differences could be used to ensure equity in service delivery and affect outcomes of antiretroviral therapy. |
| spellingShingle | Parikh, S Obuku, E Walker, SA Semeere, A Auerbach, B Hakim, J Mayanja-Kizza, H Mugyenyi, P Salata, R Kityo, C Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial |
| title | Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial |
| title_full | Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial |
| title_fullStr | Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial |
| title_full_unstemmed | Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial |
| title_short | Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial |
| title_sort | clinical differences between younger and older adults with hiv aids starting antiretroviral therapy in uganda and zimbabwe a secondary analysis of the dart trial |
| work_keys_str_mv | AT parikhs clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT obukue clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT walkersa clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT semeerea clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT auerbachb clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT hakimj clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT mayanjakizzah clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT mugyenyip clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT salatar clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial AT kityoc clinicaldifferencesbetweenyoungerandolderadultswithhivaidsstartingantiretroviraltherapyinugandaandzimbabweasecondaryanalysisofthedarttrial |